Business

Coya Therapeutics to Participate in Two Upcoming Conferences in May 2025

HOUSTON, May 08, 2025--Coya Therapeutics, Inc. (NASDAQ: COYA) ("Coya" or the "Company"), a clinical-stage biotechnology company developing biologics intended to enhance regulatory T cell (Treg) function, announces that it will participate in two upcoming conferences in May 2025.

articleCoya Therapeutics, Inc.May 8, 20255/company/coya-therapeutics-inc-common-stock/news/coya-therapeutics-participate-two-upcoming-121500710
Coya Therapeutics to Participate in Two Upcoming Conferences in May 2025

About this update from Coya Therapeutics, Inc.

[{"type":"text","content":"HOUSTON, May 08, 2025--(BUSINESS WIRE)--Coya Therapeutics, Inc. (NASDAQ: COYA) ("Coya" or the "Company"), a clinical-stage biotechnology company developing biologics intended to enhance regulatory T cell (Treg) function, announces that it will participate in two upcoming conferences in May 2025.","length":316,"tagName":"p"},{"type":"text","content":"Chief Executive Officer Arun Swaminathan, Ph.D. and Chief Financial Officer David Snyder will be available for one-on-one meetings with registered investors of the following conferences:","length":186,"tagName":"p"},{"type":"table","headerItems":[],"items":[{"val":[{"colspan":"1","rowspan":"1","style":"width:23%;","val":[{"type":"text","content":"Event:","length":6,"tagName":"p","attribs":{}}]},{"colspan":"1","rowspan":"1","style":"vertical-align:top;padding-left:0.0px;text-align:left;width:77%;","val":[{"type":"text","content":"D. Boral Capital Inaugural Global Conference","length":44,"tagName":"p","attribs":{}}]}]},{"val":[{"colspan":"1","rowspan":"1","style":"width:23%;","val":[{"type":"text","content":"Date:","length":5,"tagName":"p","attribs":{}}]},{"colspan":"1","rowspan":"1","style":"vertical-align:top;padding-left:0.0px;text-align:left;width:77%;","val":[{"type":"text","content":"May 14, 2025","length":12,"tagName":"p","attribs":{}}]}]},{"val":[{"colspan":"1","rowspan":"1","style":"width:23%;","val":[{"type":"text","content":"Registration:","length":13,"tagName":"p","attribs":{}}]},{"colspan":"1","rowspan":"1","style":"vertical-align:top;padding-left:0.0px;text-align:left;width:77%;","val":[{"type":"text","content":"Contact John Perez at [email protected]","length":46,"tagName":"p","attribs":{}}]}]},{"val":[{"colspan":"1","rowspan":"1","style":"width:23%;","val":[{"type":"text","content":"Location:","length":9,"tagName":"p","attribs":{}}]},{"colspan":"1","rowspan":"1","style":"vertical-align:top;padding-left:0.0px;text-align:left;width:77%;","val":[{"type":"text","content":"The Plaza Hotel","length":15,"tagName":"p","attribs":{}}]}]},{"val":[{"colspan":"1","rowspan":"1","style":"width:23%;","val":[]},{"colspan":"1","rowspan":"1","style":"vertical-align:top;padding-left:0.0px;text-align:left;width:77%;","val":[{"type":"text","content":"768 Fifth Avenue","length":16,"tagName":"p","attribs":{}}]}]},{"val":[{"colspan":"1","rowspan":"1","style":"width:23...

More updates from Coya Therapeutics, Inc.

Coya Therapeutics, Inc.Forward-Looking Statementsproduct candidatesclinical trialsDavid Snyderregulatory T cellCOYACoya Therapeutics, Incproduct candidatebiotechnology company